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Abstract 
Serotonin (5-HT) has a demonstrated influence on several aspects of the human 
experience including personality, behavior, and psychopathology.  One aspect of the 5-
HT system that has received considerable attention in research concerns individual 
differences in the 5-HT transporter promoter region polymorphism (5-HTTLPR) and 
their associations with behavior.  A well-researched component of the 5-HTTLPR 
literature focuses on the potential interactions between 5-HTTLPR genotype and adverse 
life events on the development of Major Depressive Disorder (MDD).  The validity of 
this interaction, however, has been questioned due to inconsistent findings.  The current 
project is an attempt to replicate the 5-HTTLPR by environment interaction in a large 
epidemiological sample, while also examining some of the proposed reasons for 
inconsistent findings.  Results consistently suggest stressful life events (SLE) are related 
to the development of MDD; however, main effects of 5-HTTLPR and the interactions 
between 5-HTTLPR variants and SLE on the development of MDD are non-significant.  
Potential reasons for these negative findings, as well as limitations of this current project, 
are discussed. 
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Chapter 1: Introduction and Background 
 
 Many studies have examined the role of the monoaminergic neurotransmitter, 
serotonin (5-HT), on personality, behavior, and psychopathology.  As the field of 
genomics advances, researchers have considered genetic influences over functional levels 
of 5-HT.  Moreover, over the past decade, increasing focus has been on potential 
interactions between 5-HT related genotypes and environmental factors, and how these 
interactions may influence the development of psychopathology.  Specifically, Caspi and 
colleagues (2003) published findings indicating that individual differences in a 
polymorphism in the promoter region of the gene that codes for the serotonin transporter 
(5-HTTLPR) interacted with adverse life events and contributed to the development of 
Major Depressive Disorder (MDD).  This seminal work has given rise to a considerable 
number of research projects and publications where researchers have attempted to 
replicate, and build upon, this gene by environment interaction.  However, findings on 
the whole have been inconsistent, and several other researchers have been unable to 
replicate this finding from Caspi et al. (2003).  These difficulties with replication have led 
many to speculate as to why these inconsistencies exist, leading to considerable 
controversy.  This project is an attempt to replicate the original Caspi et al. (2003) 
findings, as well as to investigate some of the potential reasons for the discrepancies in 
the literature on the whole. 
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Brief background summary of serotonin’s influence in various areas of human 
emotional and behavioral experiences 
A consistent finding has been that lower levels of 5-HT, as measured through 
several different techniques, are associated with higher levels of behavioral impulsivity, 
negative affect, impulsive aggression, and lower levels of social cooperativeness.  For 
instance, Knutson et al. (1998) manipulated 5-HT through the administration of a 
selective serotonin reuptake inhibitor (SSRI) over the course of four weeks in healthy 
participants.  SSRI administration would be expected to increase serotonin levels over 
time.  When compared with controls, who did not receive SSRIs, the medicated 
participants reported lower levels of impulsive aggression, irritability, and negative 
affect.  The medicated participants also demonstrated higher levels of social 
cooperativeness when asked to complete a group task.  Another study also investigated 
social cooperativeness and SSRI administration by examining SSRI administration in 
healthy individuals playing a competitive game.  Compared with unmedicated controls, 
those receiving SSRIs were considered less submissive, but also more cooperative (Tse & 
Bond, 2002).  Consequently, increased 5-HT appears to be related to both decreases in 
passivity and increases in cooperation in these experimental instances.   
 Additionally, similar results are evident when 5-HT levels are experimentally 
manipulated through acute tryptophan depletion.  Tryptophan is a precursor to 5-HT, and 
reductions in tryptophan result in decreases in the brain’s ability to synthesize 5-HT.  
Some studies have examined individual differences in aggression levels following 
tryptophan depletion.  Individuals with higher baseline levels of aggression become even 
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more aggressive and argumentative following tryptophan depletion.  Such changes are 
not seen in those with lower overall levels of aggressions (Bjork, Dougherty, Moeller, & 
Swann, 2000; Cleare & Bond, 1995). 
 Two reviews (Young & Leyton, 2002; Carver & Miller, 2006) also examine the 
literature suggesting that tryptophan depletion, along with the resulting decline in 
functional 5-HT levels, leads to increases in interpersonal aggression, while tryptophan 
supplementation generally increases social cooperativeness.  Conclusions suggest 
manipulations resulting in increases in 5-HT function result in decreases in impulsive 
aggression as well as increases in social cooperativeness and social potency or 
dominance.   
 While higher levels of 5-HT appear to improve functionality, in terms of 
increasing social cooperativeness and decreasing negative affect, high 5-HT also appears 
related to increases in symptoms of Obsessive-Compulsive Disorder.  Although this 
finding may seem counter-intuitive, some authors (e.g., Fineberg et al., 1997) have 
argued that this relationship reflects decreases in impulsivity with increased 5-HT levels.  
As discussed above, higher levels of 5-HT are associated with lower levels of aggressive 
impulsivity, and some have argued this relationship may then explain the over-controlled 
nature of those with Obsessive-Compulsive Disorder. 
 In contrast, decreases in 5-HT neurotransmission appear related to increases in 
Major Depressive Disorder (MDD).  An early focus of this research examined the relative 
amounts of the 5-HT metabolite 5-Hydroxyindoleacetic acid (5-HIAA) in cerebral spinal 
fluid of depressed patients.  The presumption has been that lower CSF 5-HIAA is 
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associated with lower levels of 5-HT in neurons (Mann 1999).  Several studies during the 
1970s and 1980s found lower levels of CSF 5-HIAA in depressed patients, particularly 
depressed patients who had attempted suicide (Mann 1998). 
 Lucki (1998) contends lower levels of 5-HT in those with MDD are largely 
consistent with the nature of symptoms of MDD.  Given serotonin’s influence on 
appetite, sleep, activity levels, sexual functioning, and cognitive functioning, it makes 
logical sense that alterations in 5-HT functioning could lead to abnormalities in these 
specific areas.  Lucki (1998) also reviews the various aspects of serotonergic dysfunction 
that are evident in MDD, including diminished levels of tryptophan in the brain, 
decreases in 5-HT synthesis or release, and dysfunction in 5-HT receptors.  Moreover, 
when 5-HT reuptake is altered through treatment with SSRIs, depressive symptoms are 
typically reduced (for a meta-analysis on SSRI efficacy, see Anderson, 2000). 
 Several decades of research have implicated 5-HT in MDD, where lower 
functional levels of 5-HT are associated with MDD (e.g., Mann 1999; Mann 1998; Lucki 
1998).  This conclusion has been supported through research in various methodological 
areas, including apparent reductions in CSF 5-HIAA in depressed patients, reduced 
plasma concentrations of tryptophan in depressed patients, and the clinical efficacy of 
anti-depressants targeting the 5-HT system (Owens & Numeroff, 1994). 
 
The Serotonin Transporter Polymorphism (5-HTTLPR) 
 One portion of the 5-HT system that has received attention for its potential 
influence on aspects of personality and psychopathology is the serotonin transporter (5-
  5 
HTT).  5-HTT is a protein found in the membranes of pre-synaptic neurons.  5-HTT is 
responsible for taking synaptic 5-HT back into the pre-synaptic neuron, thereby ending 
its potential for activity in the synaptic cleft (Seretti, Calati, Mandelli, & De Ronchi, 
2006).  5-HTT synthesis is coded by the gene SLC6A4 located on chromosome 17.  One 
way that 5-HTT transcriptional activity is controlled is through a repetitive sequence on 
the SLC6A4-linked polymorphism (5-HTTLPR).  Individuals vary in terms of whether 
they possess a short sequence versus a long sequence.  One copy of the sequence is 
transmitted from each parent.  These short and long versions influence 5-HTT function 
(Canli & Lesch, 2007), such that those with the short (S) variant experience apparent 
decreases in the 5-HTT expression and activity compared with those who have the long 
(L) variant (Seretti, et al., 2006).  Therefore, importantly, the behavioral differences 
conferred by these different polymorphisms exist, because it is believed the S variant 
leads to comparably lower 5-HT activity.  Please see Figure 1 for a graphic representation 
of the long and short variants and 5-HTT function. 
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Figure 1.  Graphical representation of 5-HTTLPR on serotonergic function from Canli 
and Lesch, 2007.  The short variant is in purple, and leads to significantly less 5-HTT, 
which results in greater synaptic concentrations of 5-HT compared with the long variant 
(red).  The short variant has shown to be related to anxiety and affective difficulties 
(Canli & Lesch, 2007). 
 
 Although individual differences in 5-HTTLPR represent only one way of 
examining 5-HT activity, group differences between S and L carriers have been found 
over several biological and psychological measures.  One brain region that has received 
considerable attention is the amygdala due to its apparent role in stress reactivity and 
MDD (Whalen, Shin, Somerville, McLean, & Lim 2002).  For instance, when comparing 
brain function, differing levels of amygdala activation in response to environmental 
stimuli are observed as a function of the 5-HTTLPR genotype.  Heinz and colleagues 
(2005) found that healthy individuals (e.g., non-depressed) who were S carriers exhibited 
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greater amygdala activation when viewing aversive visual stimuli.  Healthy (e.g., non-
depressed) S carriers were also found to have greater amygdala activation when faced 
with threatening environmental stimuli by Hariri et al. (2005).   
 More recently, Kruschwitz et al. (2014) examined 5-HTTLPR and its influence on 
both neuroticism and resting state functional connectivity of the amygdala and fusiform 
gyrus.  These authors found a correlation between neuroticism and 5-HTTLPR status, as 
well as altered amygdala and fusiform gyrus activity when observing negative faces.  
Neuroticism and both amygdala and fusiform gyrus activity were higher in S carriers. 
 Munafo, Brown, and Hariri (2008) performed a meta-analysis of 14 studies that 
examined 5-HTTLPR and amygdala activation.  This meta-analysis supported the overall 
finding that S carriers exhibit increased amygdala activation in response to negative 
environmental stimuli.  Specifically, these authors suggested 10% of the phenotypic 
differences in amygdala reactivity appeared related to genotypic status.  However, a 
subsequent meta-analysis, published in 2013, contends this figure is an overestimation, 
and likely the result of publication bias.  Specifically, Murphy and colleagues (2013) 
performed a meta-analysis, which included 34 samples.  These authors found a small, but 
consistent, effect of 5-HTTLPR variants on amygdala activation, where S carriers 
showed greater activation.  The authors of this study report that 5-HTTLPR status may 
account for approximately 1% of the phenotypic differences in amygdala activation 
(Murphy et al., 2013).  Furthermore, Bastiaansen and colleagues (2014) found no 
relationship between in both a replication study and a meta-analysis including 
unpublished data.  The authors conclude the relationship between 5-HTTLPR and 
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amygdala activation is likely smaller than previously indicated, or perhaps does not exist 
at all. 
 Some researchers have also focused on the relationship between 5-HTTLPR 
status and anxiety and neuroticism.  These findings have been mixed.  Gonda and 
colleagues (2009) examined healthy females and found that S carriers had higher scores 
on measures related to negative emotionality, including anxiety and depression 
symptoms, though subclinical.  Clarke, Flint, Attwood, and Munafo (2010) performed a 
meta-analysis looking at the main effect of 5-HTTLPR variants on MDD.  This group 
found a small, but significant, effect of 5-HTTLPR on MDD, where S carriers appeared 
to have greater risk of developing the disorder.  However, other groups (e.g., Middledorp 
et al., 2007; Vinberg, Mellerup, Andersen, Bennike, & Kessing, 2009) have not found a 
main effect of 5-HTTLPR status on neuroticism or negative affect. 
 In terms of risks associated with the L allele, Glenn (2011) suggests there are 
psychophysiological and neurological findings that suggest L homozygotes may be more 
prone to psychopathy compared with S carriers.  Specifically, Glenn (2011) reviews 
literature suggesting L homozygotes are more likely to show decreased amygdala 
reactivity to negative stimuli, reduced error processing in the prefrontal cortex, reduced 
resting heart rate, and reduced skin conductance during fear conditioning.  These findings 
are also evident in psychopathy (Glenn 2011). 
 Consequently, there are various avenues of 5-HT research suggesting that, 
overall, lower levels of 5-HT as conferred by the S variant of 5-HTTLPR are related to 
negative affect and neuroticism (e.g., Carver & Miller, 2006), while it has also been 
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suggested that L homozygotes may be more prone to the development of psychopathy 
(Glenn 2011).  Furthermore, S carriers may experience lower levels of overall 5-HT, and 
subsequently greater amygdala reactivity in response to stressful stimuli (e.g., Murphy et 
al., 2013) and increases in negative affect (e.g., Gonda et al., 2009).  However, these 
findings are inconsistent in the literature with several groups being unable to find an 
association between 5-HTTLPR and affect (e.g., Middledorp et al., 2007). 
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Chapter 2: Interactions between 5-HTTLPR variants and Stressful Life Events 
(SLE) on the development of Major Depressive Disorder (MDD) 
 
 In addition to the main effect of 5-HTTLPR genotype on aspects of emotion, 
aggression, and neural function, researchers have also focused on an interaction between 
5-HTTLPR status and environmental stressors, and how this relationship may influence 
internalizing psychopathology, particularly MDD.  Caspi and colleagues (2003) 
investigated this relationship between 5-HTTLPR status and stressful life events (SLE) 
on the development of MDD in young adults.  At the age of 26 years, participants 
(N=847) were assessed for SLE occurring within the previous five years using a life 
events calendar interview.  SLE included difficulties ranging from employment, finances, 
housing, health, and relationships.  These subjects were also assessed for MDD within the 
past year through structured diagnostic interviews.  Findings indicated that when exposed 
to life stressors between the ages of 21 and 26 years, individuals with the S variant of 5-
HTTLPR (including both S/S and S/L individuals) were more likely to receive an MDD 
diagnosis, whereas such a relationship was not seen in the L/L individuals.  In an effort to 
examine the potential reasons behind the gene by environment interaction, Caspi et al. 
(2010) discuss the possibility that having an S allele makes it more likely that individuals 
will have higher levels of neuroticism, as supported by Ball et al. (1997) and Lesch et al. 
(1996).  Then, when this heightened neuroticism is coupled with adverse life 
circumstances, the interaction results in the development of MDD. 
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 The Caspi et al. (2003) gene by environment finding led to several subsequent 
papers that further examined this interaction.  Some researchers have found evidence to 
support Caspi et al. (2003) and suggest that S carriers are more likely to experience MDD 
in the face of adverse life events (e.g., Daniele et al., 2011; Vervilla et al., 2007; Kendler 
et al., 2005).  However, others have not been able to replicate these findings (e.g., 
Munafo, Durrant, Lewis, & Flint, 2009; Risch et al., 2009) or have only found this 
relationship to exist in certain groups, such as females (e.g., Åslund et al., 2009).  
Additionally, other authors have reported the opposite pattern, where the L allele confers 
great risk for MDD when exposed to SLE (Chipman et al., 2007; Luacht et al., 2009). 
 
Controversies and Inconsistencies in the 5-HTTLPR Gene by Environment 
Interactions Research 
 Munafo and colleagues (2009) carried out a meta-analysis of studies examining 
the relationship between SLE and the 5-HTTLPR genotype.  This group identified 14 
studies that examined the potential relationship between SLE and 5-HTTLPR genotype 
with MDD as an outcome measure.  The results of this meta-analysis suggest that very 
few studies have replicated the original finding of Caspi et al. (2003).  Additionally, they 
argued that the SLE by 5-HTLLPR literature is rife with studies suffering from low 
power, and consequently, the occasional positive findings are likely due to chance. 
 Similarly, Risch et al. (2009) also performed a meta-analysis including 14 studies 
investigating SLE by 5-HTTLPR interactions and the development of MDD.  Like 
Munafo et al. (2009), Risch et al. (2009) found no evidence of an interaction between 
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SLE and 5-HTTLPR genotype on MDD, but did identify a main effect of SLE on the 
development of MDD. 
 Many responses to Risch et al. (2009) have been published, including several 
letters to the editors of the Journal for the American Medical Association (JAMA), where 
the results were initially published, as well as in other publications.  In a response 
published by the Archives of General Psychiatry, Michael Rutter (2009) raised several 
criticisms regarding the analytic approach taken by Risch et al. (2009).  Rutter argued 
that the inclusion and exclusion of the studies was inconsistent and not representative of 
the literature in its entirety.  He also raised questions about the generalizability of their 
findings, given different studies used different measures and methods for obtaining data.  
Although Risch et al. (2009) did attempt to recode SLE data in order to gain some 
consistency, given the significant heterogeneity in the data across studies Rutter argues 
this method may reduce statistical power (2009).  Furthermore, Rutter criticizes Risch et 
al.’s (2009) lack of comprehensiveness, saying that to truly appreciate and understand the 
gene by environment interactions, data from the animal literature, as well as data 
regarding medication response in humans, should be considered.  Therefore, Rutter 
believes considerable areas of research supporting the 5-HTTLPR gene by environment 
interactions were not given appropriate consideration in Risch et al. (2009) (Rutter, 
2009). 
 Palla, Higgens, Wareham, and Sharp (2010) also raise methodological issues with 
Risch et al. (2009) and with meta-analyses in general.  These authors argue that meta-
analyses are problematic when investigating gene by environment interactions.  Similar 
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to concerns raised by Rutter (2009), Palla et al. (2010) suggest that meta-analyses in this 
area of research are highly problematic because of the lack of consistency in measures 
across studies.  In terms of inconsistent measures, the definition of SLE is ill-defined, 
and, depending on the specific study, can vary greatly from childhood maltreatment (e.g., 
Kaufman et al., 2006) to chronic disease or unemployment (e.g., Grabe et al., 2005).  
Furthermore, the measures of MDD also vary greatly.  Some studies rely on 
questionnaire methods while others use fully structured or semi-structured interviews 
(Risch et al., 2009).  Palla et al. (2010) are also highly critical of the meta-analytic 
approach in gene by environment research due to the heterogeneity in both study design 
and statistical analytic methods used, and the bias in both the publication of only positive 
findings as well as bias in terms of what studies are selected for inclusion.  While these 
are often issues for meta-analytic approaches in general, Palla et al. (2010) argue they are 
even greater hurdles for gene by environment interaction research, given that the focus is 
on interactions.  These authors contend these interactions involve greater inconsistency in 
the statistical analytic approaches, as well as inconsistency in how these interactions are 
reported compared with meta-analyses that focus on main effects.  These authors 
subsequently conclude that meta-analyses focusing on gene by environment interactions 
are not likely to “provide meaningful quantitative conclusions,” and time and energy 
should instead be spend establishing consortia in order to establish more homogeneity in 
the data (Palla et al., 2010). 
 Karg, Burmeister, Shedden, and Sen (2011) performed a more inclusive meta-
analysis using a different method of combining data, which they argue is more 
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appropriate than the methodology used in meta-analyses elsewhere (e.g., Munafo, et al., 
2009; Risch et al., 2009).  These authors used a statistical method to combine p-values 
across studies as opposed to using raw data (as was done in Risch et al., 2009).  The 
authors suggest this method addresses issues with the methodological heterogeneity in 
the different studies including their meta-analysis.  Karg et al. (2011) performed a meta-
analysis including 54 studies examining this gene by environment interaction.  Moreover, 
this group also used the 14 studies specifically reviewed by Risch et al. (2009) separately 
to evaluate their analytic procedures. 
 When all 54 studies were included and this different data extraction method was 
used, Karg et al. (2011) found evidence to support an interaction between SLE and 5-
HTTLPR genotype on the development of MDD.  Specifically, the authors contend this 
relationship is particularly robust when childhood maltreatment is used as the SLE.  
However, when only using the 14 studies from Risch et al. (2009), this group also failed 
to find a gene by environment interaction leading to MDD.  However, Karg et al. (2011) 
report that when more studies are included, and a statistical technique involving the 
combination of p-values is used opposed to the combination of raw data, the gene by 
environment interaction is found.  Additionally, these authors argue childhood 
maltreatment is a specific form of SLE that leads to significant gene by environment 
findings (Karg et al., 2011). 
 In another attempt to discount the results of Munafo et al. (2009) and Risch et al. 
(2009), Caspi and colleagues (2010) criticize the use of paper/pencil self-report measures 
to quantify adverse life events.  They believe in-depth, face-to-face interviews are 
  15 
preferable for collecting valid data.  Furthermore, as argued by others described above 
(e.g., Rutter, 2009; Karg et al., 2011) the authors note what is meant by “life stressors” is 
tremendously heterogeneous.  Different studies define SLE in drastically different ways, 
and may use the term to include several non-specific life experiences.  Consequently, 
Caspi et al. (2010) believe the best, most consistent data are found when a very specific 
and narrow definition of life stressor is used, and that too much variability is introduced 
when the net is cast too widely.  Even more specifically, Karg et al. (2011) suggest 
childhood maltreatment may provide the most robust results when examining this gene 
by environment interaction. 
 In addition to the methodological differences in data collection, and the 
heterogeneity in the definition of SLE, several other publications have suggested various 
reasons for the inconsistency in findings within the 5-HTTLPR gene by environment 
interaction research.  Uher and colleagues (2011) found an interaction between childhood 
maltreatment and 5-HTTLPR status on “persistent” MDD, but not for single episodes.  
Using a longitudinal approach, this group found the S allele conferred greater risk for the 
development of persistent MDD (having a diagnosis of MDD a minimum of two times 
out of four assessments) when coupled with childhood maltreatment.  However, another 
group failed to find any gene by environment interaction involving SLE and 5-HTTLPR 
variants on persistent MDD (Fisher et al., 2012).  It is potentially notable, however, that 
this second publication used SLE focusing on serious illness of self, serious illness or 
death of loved ones, financial problems, among other environmental stressors (from 
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Brugha, Bebbington, Tennant, & Hurry, 1985), but did not use any SLE variables 
involving childhood maltreatment in their analyses.  
 Duncan and Keller (2011) raise several valid criticisms of the gene by 
environment interaction research in psychiatry.  In their review, they contend the positive 
findings in the literature are likely the result of publication bias.  To support this 
contention, the authors note that 96% of novel gene by environment findings reported in 
the literature were positive.  However, when replications were examined, only 27% of 
these were positive (Duncan & Keller, 2011).  Additionally, they point out that articles 
where replication occurs have significantly smaller sample sizes than those failing to 
replicate.  For instance, they report the median sample size in studies replicating gene by 
environment interactions was 154, while the median sample size of reports not supporting 
the gene by environment findings was 377.  They argue if the gene by environment 
findings are valid, larger samples should be more likely to replicate interactions.  They 
also criticize the Caspi et al. (2010) argument that larger studies have poorer measures of 
SLE and MDD.  Duncan and Keller (2011) insist that even if this argument were true, it 
would not explain why there are more failures to replicate in the literature on the whole, 
or why studies with negative findings alone always appear to have the largest sample 
sizes.  Consequently, Duncan and Keller (2011) believe the majority of the positive gene 
by environment findings are the result of publication bias. 
 This controversy clearly indicates significant problems with the current 
understanding of gene by environment interactions, particularly in reference to 5-
HTTLPR and SLE, and their influences on the development of MDD.  As discussed 
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above, several inconsistencies have been found in the published literature; however, 
whether these inconsistencies simply reflect a poverty in data quality (as suggested by 
Caspi et al., 2010; Uher & McGuffin, 2010) or important information contradicting the 
validity of the 5-HTTLPR and SLE interactions (as proposed by Risch et al., 2009; 
Munafo et al., 2009; Duncan & Keller, 2011) remains to be seen. 
 
Relative Independence or Dependence of Stressful Life Events (SLE) and Genetic 
Background 
 A potential complication in the gene by environment interaction research comes 
from considering the relative dependence or independence of adverse life events, where 
individuals with certain genetic backgrounds may be more likely to experience certain 
stressful life events (SLE).  For instance, a child may have a particularly difficult 
temperament due, at least in part to his or her genetic background.  Then, if he or she is 
expelled from school because of these difficulties, it is likely his or her genes are 
influencing this specific environmental stressor (Scarr & McCartney, 1983).  This 
relationship between genetic background and environmental stressors may complicate the 
investigation of gene by environment interactions since these two factors are apparently 
not entirely independent of one another.  The potential interdependence between genes 
and environment has also not been considered when investigating the relationship 
between 5-HTTLPR and SLE.  Furthermore, since approximately one-third of the 
relationship between SLE and MDD is due to common genes (Kendler et al., 1999), it 
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may be possible the relationship between SLE and MDD may over-estimate any potential 
gene by environment interaction (Boardman, Alexander, & Stallings, 2011). 
 
Summary 
 One relatively common way of investigating the influence of 5-HT on several 
phenotypes is through examining the 5-HTTLPR genotype, where different 
polymorphisms appear to confer different levels of risk for certain kinds of 
psychopathology.  Several studies have suggested that S carriers experience greater 
activity in the amygdala when presented with negative stimuli, as well as tendencies 
towards greater negative affect, although these findings are inconsistent.  In addition to 
these main effects of 5-HTTLPR, another area of research has grown around the concept 
that 5-HTTLPR may predispose some individuals to develop MDD when confronted with 
adverse life events.  As discussed above, these gene by environment findings are also 
inconsistent, and have led to great debate within the field.  Several potential reasons for 
these discrepant findings have been posited, including the quality of data acquisition (in-
person interviews versus paper/pencil questionnaires) and the nature of which adverse 
life events may be more likely to lead to MDD in S carriers.  Despite these many 
arguments presented to explain the discrepant gene by environment findings, questions 
remain as to why such inconsistency exists.  In the analyses below, some of the potential 
reasons for these inconsistencies will be investigated. 
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Chapter 3: Current Project 
 
 With the current project, the relationship between the 5-HTTLPR genotype and 
SLE on MDD will be investigated in a large epidemiological sample of individuals who 
contributed various sources of data on history of SLE in the context of a longitudinal 
study.  With the large, longitudinal dataset obtained and maintained by the Minnesota 
Center for Twin and Family Research (MCTFR), interactions between the 5-HTTLPR 
variants and SLE can be examined in detail.  The dataset is larger than many of the 
previously published reports, including the original Caspi et al. (2003) publication.  
Furthermore, this dataset includes several high quality interview data measures.  As Caspi 
et al. (2010) suggested, brief self-report forms assessing SLE may be insufficient.  
Moreover, this large dataset is longitudinal, and thus the relationship between 5-HTTLPR 
variants and adverse life events can be evaluated over the course of several years 
(between 6 and 9 years) as opposed to one or two time points that span shorter durations, 
which may be important given the contention of Uher et al. (2011) that gene by 
environment interactions may only be seen in “persistent” MDD. 
 
Specific aim 1a: Replication 
 The first goal of these analyses is an attempt to replicate the original gene by 
environment interaction found by Caspi et al. (2003) in a sample of individuals from the 
Minnesota Center for Twin and Family Research (MCTFR).  This sample of individuals 
was evaluated between the ages of 17 and 25 years.  During this time, the participants’ 
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total stressful life events (SLE) were measured through the Life Events Interview (LEI: 
Billig, Herschberger, Iacono, & McGue, 1996).  The occurrence of Major Depressive 
Disorder (MDD) was also determined during this period.  In an effort to replicate Caspi et 
al. (2003), it will be investigated whether S carriers have higher rates of MDD at age 25 
years compared with L/L individuals when exposed to higher levels of SLE between the 
ages of 17 and 25 years, while the different genotypes will not differ in MDD rates at low 
levels of SLE.  Consistent with the compelling arguments of Duncan & Keller (2011), 
and the analyses of Risch et al., (2009) and Munafo et al., (2009), it is hypothesized that 
no significant interaction between genotype and SLE (when SLE are broadly defined) on 
the development of MDD will be found.  Thus, it is anticipated that Caspi et al. (2003) 
will not be replicated. 
 
Specific Aim 1b: Childhood Maltreatment 
 Within the context of this overarching analysis, childhood maltreatment may be 
isolated as a specific kind of SLE, which may be examined in additional analyses, since 
some authors have suggested this form of SLE may be most likely to lead to a gene by 
environment interaction (e.g., Karg et al., 2011).  Lifetime experiences with childhood 
maltreatment through the age of 18 years, as measured through the Childhood Experience 
Questionnaire (CEQ: e.g., Bornovalova, et al., 2012) will be used.  If Karg et al. (2011) is 
correct about the influence of childhood maltreatment on this gene by environment 
interaction for MDD, it would be hypothesized that a significant gene by environment 
interaction on the occurrence of MDD will be found.  However, it is difficult to ascertain 
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why different “kinds” of stressful life events would impact differences in genetic risk for 
MDD.  Consequently, despite the contention of Karg et al. (2011), it is hypothesized that 
no significant interaction between 5-HTTLPR variants and childhood maltreatment on 
the occurrence of MDD will be found. 
 
Specific Aim 1c: Persistent MDD 
 As these data are longitudinal, “persistent” MDD, as described by Uher et al. 
(2011) can also be assessed.  Persistent MDD will be defined as the occurrence of MDD 
at two or more time points through assessments at the approximate ages of 17, 20, and 25 
years.  SLE will be measured using the Life Events Interview (LEI) data through the age 
25 assessment.  It is hypothesized that S carriers will be more susceptible to persistent 
MDD when facing higher levels of SLE compared with L/L participants, but rates of 
MDD will not differ between genotypes at low SLE levels.  It is important to note that 
within the persistent MDD analyses, SLE and the diagnosis of MDD are concurrent. 
 
Specific Aim 2 
 Since genes and environment are not completely independent of one another, 
one’s genetic background may influence the kinds of environmental stressors one 
experiences.  Adverse life events taken from the Life Events Interview (LEI) discussed 
above were studied by Bemmels, Burt, Legrand, Iacono, and McGue (2008).  These 
authors created three scales: independent life events (SLE likely to not be influenced by 
the participant, e.g., being mugged or robbed), dependent adverse life events (SLE that 
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may be influenced by the participant, e.g., spending time in jail), and familial adverse life 
events (experienced by a member of the family).  Please see Appendix C for the events 
considered dependent and independent from this publication.  Results indicated additive 
genetic effects contributed significantly to the dependent events, while nonshared 
environmental effects contributed most to the independent life events.  The largest 
contributor to the familial life events involved shared environmental effects.  These 
results suggest genetic background may have considerable impact on certain kinds of life 
events. 
 In adolescence and young adulthood, it is estimated that approximately 37% of 
the variance in the development of MDD is due to genetic factors (Sullivan, Neal, & 
Kendler, 2000) and approximately one-third of the relationship between SLE and MDD 
is due to the common genes (Kendler, et al., 1999).  Consequently, it would make sense 
that the relationship between dependent SLE and MDD may over-estimate any potential 
gene by environment interaction (Boardman et al., 2011).  The goal of Specific Aim 2 is 
to investigate whether independent forms of SLE interact with the 5-HTTLPR genotype 
in influencing the development of MDD differently than the dependent forms of SLE.  It 
is hypothesized that dependent SLE will show a significant gene by environment 
interaction on the development of MDD, while independent SLE will not show a 
significant interaction.  If dependent SLE interact with 5-HTTLPR and independent SLE 
do not, it may suggest studies using dependent SLE in gene by environment research may 
be over-estimating the gene by environment interaction because the presence of 
dependent SLE and MDD may simply be coming from the same underlying genes.   
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Specific Aim 3: Negative Emotionality and 5-HTTLPR Genotype 
 As discussed above, there is a potential relationship between 5-HTTLPR and 
negative affect (e.g., Ogilvie et al., 1996; Kurschwitz et al., 2014).  Specifically it will be 
investigated whether S carriers have significantly higher negative affect compared with 
L/L individuals, and whether negative affect, when coupled with SLE may lead to MDD.  
Data from the Multidimensional Personality Questionnaire (MPQ: Tellegen, 1982) 
include the scale Negative Emotionality (NEM), which is comprised of subscales 
including stress reactivity, alienation, and aggression.  It will be investigated whether 5-
HTTLPR genotype is related to NEM at age 17, and whether NEM at age 17 influences 
the development of MDD by age 25 years.  It is hypothesized that S carriers will be more 
likely to experience higher levels of NEM, which will influence the frequency with which 
they experience MDD. 
 
 
  24 
 
Chapter 4: Methods 
 
Sample 
 Participants are individuals enrolled in research with the Minnesota Center for 
Twin and Family Research (MCTFR: Iacono, McGue, & Krueger, 2006), a longitudinal 
epidemiological series of studies examining twins born in Minnesota, as well as their 
siblings and parents.  The MCTFR data have been collected with an emphasis on 
psychological adjustment in twins and family members, with a special interest in 
externalizing psychopathology and substance use disorders (Iacono et al., 2006).  The 
MCTFR began with two cohorts, twins aged 11 or 17 years when initially enrolled.  
Participants were identified through public birth records between 1972 and 1978 in the 
case of the 17-year-old cohort and between 1978 and 1982 in the case of the 11-year-old 
cohort.  More than 90% of the same sex male and female twins born during these 
respective time periods were located for inclusion in this research project.  Individuals 
were excluded if either twin had a serious physical or cognitive disability that would 
prevent them from engaging in the assessments or if they lived farther than one day’s 
drive from the labs in Minneapolis.  A total of 78% of eligible families agreed to 
participate, and the sample (98% Caucasian) was representative of the overall racial 
make-up of Minnesota during the years of recruitment.  After initial participation in this 
project, twins were invited back in approximate 3-year intervals for testing. 
 The current study uses a subset of this dataset.  The total dataset examined 1,517 
twins at intake in the 11-year-old cohort and 1,252 twins at intake for the 17-year-old 
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cohort.  However, not all of these participants provided DNA samples, and subsequently 
fewer individuals are used in these current analyses.  Individuals were included in this 
current project if they contributed DNA, have MDD data from the Structured Clinical 
Interview for the DSM-III R (SCID) (Spitzer et al., 1990) at the three time points 
discussed below, and had completed the Life Events Interview (LEI) at the three time 
points discussed below.  This method of inclusion yielded a total of 740 participants from 
the younger cohort and 729 participants from the older cohort, totaling 1,469 individuals 
(53% of the 2,769 who completed an intake assessment).  These 1,469 participants in the 
current analyses did not differ in terms of reported SLE at age 25 assessment from those 
without genotyping data (who were therefore excluded) in either the younger cohort 
(included: M= 6.35, SD= 3.31; excluded: M=6.67, SD=3.75) (t(1311) = -1.599, p = 0.110)  
or the older cohort (included: M= 6.69, SD=3.27; excluded 6.28, SD=3.08) (t(1112) = 
1.964, p = 0.050).  The excluded participants in the neither the younger (χ2  (1, N=1206) = 
0.932, p = 0.334) nor the older cohort (χ2  (1, N=1108) = 0.001, p=0.979) differed 
significantly in rates of MDD from those included in the study. 
 To increase the overall N, the 11 and 17-year-old cohorts were combined for 
analyses.  The data from three time points was used, when the participants were an 
average of 17.81 years, 21.07 years, and 24.94 years.  These data points are labeled Age 
17 Assessment, Age 21 Assessment, and Age 25 Assessment respectively.  In order to 
use both cohorts at these ages, data from follow-up 2, 3, and 4 were used from the 
younger cohort and data from intake, follow-up 1, and follow-up 2 were used from the 
older cohort.  Table 1 summarizes the number of individuals with genotyping data, MDD 
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data, and LEI data by cohort and follow-up.  Table 2 displays rates of MDD, total SLE, 
independent SLE, and dependent SLE by gender and genotype. 
 
Table 1  
 
Participant Characteristics 
 
 
Assessment   Younger Cohort Older Cohort  Total   
 
Total 
N   740   729   1469 
Number male  362   325   687 
 
Age 17    
 Mean Age (SD) 18.13 (0.70)  17.47 (0.46)  17.79 (0.67) 
 
Age 21   
 Mean Age (SD) 21.43 (0.78)  20.66 (0.55)  21.03 (0.78) 
 
Age 25 
 Mean Age (SD) 25.22 (0.67)  24.65 (0.89)  24.92 (0.84) 
 
 
Note.  Participants from each cohort, by assessment, including mean age and standard  
deviations. 
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Table 2 
 
Number (and percentages) of participants with MDD at Age 25 Assessment, SLE, ISLE, 
and DSLE at Age 25 Assessment by gender and genotype. 
 
 
 
  Female     Male 
 
  S/S  S/L  L/L  S/S  S/L  L/L  
 
MDD 20  58  31  11  25  17  
12.7%             15.8%  12.1%  8.4%  7.7%  7.4% 
 
SLE      12.37   12.62  11.83  13.10  13.04  12.28 
   (4.82)  (5.13)  (5.22)  (5.75)  (6.27)  (5.71) 
 
ISLE  1.69  1.81  1.69  1.53  1.90  1.21 
   (2.76)  (2.53)  (2.71)  (2.31)  (3.34)  (2.21) 
 
DSLE  2.59  3.11  2.52  2.99  2.84  2.66 
  (3.60)  (7.58)  (2.76)  (4.95)  (3.99)  (4.14) 
 
 
Note.  Mean (SD) Stressful Life Events (SLE), Independent Stressful Life Events (ISLE),  
and Dependent Stressful Life Events (DSLE) by gender and genotype. 
 
Measures 
 The presence or absence of MDD was determined using an altered version of the 
Structured Clinical Interview for the DSM-III R (SCID) (Spitzer et al., 1990), using 
criteria from the DSM-III R.  The interviewers had psychology backgrounds and 
underwent considerable training in diagnostic interviewing.  Consensus meetings were 
held with a minimum of two graduate students or individuals with advanced training in 
the area of psychological assessment, and tapes of the interviews were reviewed.  A 
sample of 600 study participants were selected and yielded a kappa reliability of .78 
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(Wilson, Vaidyanathan, Miller, McGue, & Iacono, 2014).  Persistent MDD, taken from 
Uher et al. (2011), is defined as individuals meeting criteria for MDD at two or more time 
points between the ages of 17 and 25 years. 
 The 17-year-old cohort had lifetime prevalence of MDD measured at their intake 
and follow-up 1, at approximate ages 17 and 21.  Cases of MDD occurring in this cohort 
between intake and follow-up 1 were extrapolated by identifying those reporting MDD 
episodes at follow-up 1 that did not report episodes at intake.  At follow-up 2, at 
approximate age 25, this cohort reported new cases of MDD occurring since follow-up 1. 
 In terms of the 11-year-old cohort, these participants were asked to report 
symptoms of MDD that occurred prior to intake.  Each subsequent follow-up assessed 
MDD as it had occurred over the previous three years. 
 The SLE data include the Life Events Interview (LEI: Billig, Herschberger, 
Iacono, & McGue, 1996).  This in-person interview was completed by participants at 
each assessment and asks about a broad range of potential adverse life events.  The 
definition of SLE in this interview is variable and includes several life events that may 
differ greatly in their perceived intensity (e.g., having a fight with a close friend versus 
the death of a loved one).  A total of 45 questions were used from each visit.  For a list of 
SLE questions used in these analyses, please see Appendix A.  At intake, participants 
were asked whether these incidents had occurred during their lifetimes, and at each 
subsequent follow-up they were asked to report incidents having occurred in the previous 
three years.  Total number of SLE was summed across the questions asked, with 45 being 
the maximum number of SLE that could be endorsed at each time point.  This variable 
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was then divided into quartiles, and four groups were created indicating minimal, mild, 
moderate, or high incidence of SLE (e.g., Risch et al., 2009).  For the ranges, means, and 
standard deviations for each of these four groups, please see Table 3. 
 
Table 3  
 
The range of SLE, means, and standard deviations in each of the four LEI groups. 
 
 
Group   N  Range of SLE   Mean (SD)    
 
Group 1  364  0.00 – 8.00   6.31 (1.68) 
 
Group 2  467  9.00 – 12.00   10.58 (1.14) 
 
Group 3  342  13.00 – 16.00   14.28 (1.12) 
 
Group 4  296  17.00 – 45.00   20.63 (3.98) 
 
 
 
 The other method used to measure SLE is from the Childhood Experience 
Questionnaire (CEQ: e.g., Bornovalova et al., 2012).  This self-report questionnaire was 
given after the participants reached adulthood and asked them to think back upon their 
childhood and potential abusive or neglectful incidents they may have experienced 
through the age of 18 years.  These data were collected at follow-up 4 (approximate age 
24.99 years) for the 11-year-old cohort.  In terms of the 17-year-old cohort, these data 
were collected from female participants only at follow-up 3 (approximate age 29).  
Consequently, only the younger cohort is included in these analyses.  For a list of the 
SLE data included in this self-report questionnaire, please see Appendix B.  The total 
number of events was summed.  As with the SLE from the LEI, 4 groups were created 
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indicating whether the participants had experienced 0 (N = 197), 1 (N = 243), 2 (N = 
108), or 3 or more (N = 232) negative life events described in this questionnaire.  This 
method yielded four levels of SLE, which, again, is similar to the approach taken in Risch 
et al. (2009). 
 Negative emotionality (NEM) was derived from the Multidimensional Personality 
Questionnaire (MPQ: Tellegen 1982).  NEM is comprised of three subscales, including 
aggression, alienation, and stress reactivity.  NEM data from females and males in both 
the younger and older cohorts at the Age 17 Assessment were included in these analyses.  
It was investigated whether NEM at the Age 17 Assessment was related to the presence 
of MDD at the Age 25 Assessment, and whether NEM at the Age 17 Assessment 
interacted with SLE on the presence of MDD at age 25. 
 
Statistical Analyses 
 Generalized Estimating Equations (GEE) were used to determine the level of risk 
for MDD associated with each factor, which included gender, 5-HTTLPR status (coded 0 
for L/L individuals, 1 for L/S individuals, and 2 for S/S individuals), cohort (either the 
younger or older cohort), and the number of SLE coded on a 4 point scale, as well as 
interactions between these variables.  GEE was used because this analytic method allows 
for the interrelatedness of subjects (twins) while extending the general linear model 
(Hardin & Hilbe 2013).  The sample used in these current analyses had 66.3% 
monozygotic twins.  In terms of the model, an unstructured working correlation matrix 
was used, and statistical significance was determined using the p-value from the Wald 
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type 3 statistic.  Since the outcome variable was dichotomous (depressed versus not 
depressed) a binary logistic regression model was used.  Analyses were completed using 
SPSS version 20 for Macintosh computers. 
 No assumptions regarding additivity or dominance of 5-HTTLPR effects were 
made beforehand.  Analyses were performed for both the additive and dominance 
models, where the additive model compared the three 5-HTTLPR variants (S/S, S/L, and 
L/L) and the dominance model focused on the presence of the S allele by comparing S/S 
and S/L individuals to L/L individuals.  Like Caspi et al. (2003), an additive model was 
used where the genotype was coded 0, 1, or 2, representing the number of S alleles each 
individual has.  The dominance model compares L homozygotes to S carriers, and these 
participants are coded as either 0 or 1, where 1 indicates the presence of at least one S 
allele.   
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Chapter 5: Results 
 
 The sample was comprised of 19.7% S/S, 47.2% S/L, and 33.1% L/L individuals, 
which does not deviate from the Hardy-Weinberg equilibrium (χ2 (2) = 1.4339, p > 0.50).  
Results of an ANOVA suggest the L homozygotes had significantly lower rates of SLE 
compared with the heterozygotes (F(2, 1466) = 4.165, p=0.016).  No other significant 
differences regarding SLE between the genotypic groups were noted.   
Findings, which generally do not confirm the studies hypotheses, are organized by 
aim. 
 
Specific Aim 1a: Replication 
 First, in an attempt to replicate Caspi et al. (2003), the relationship between SLE 
and 5-HTTLPR on the presence of MDD at age 25 was investigated with both additive 
and dominance models.  SLE was measured through adding the total LEI events reported 
between the 17 and 25 year assessments.  The presence of MDD, likewise, was measured 
between the 17 and 25 year assessments.  Gender and cohort were also included in this 
model.  For a summary of the average LEI reported at each visit, as well as the 
percentage of participants with MDD at age 25, please see Table 2. 
Additive Analyses 
 Results indicate a significant main effect of SLE on the presence of MDD at age 
25 years, where greater SLE was associated with higher rates of MDD.  There was no 
significant main effect of cohort, gender, or 5-HTTLPR on the presence of MDD, nor 
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were any interactions between these variables significant in their influence over MDD.  
For a summary of these results, please see Table 4 and Figure 2.   
 
Table 4 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, LEI, and 
5-HTTLPR on the presence of MDD at age 25 
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.439 (1)   .508 
  Cohort    3.830 (1)   .050 
  5-HTTLPR   0.002 (1)   .961 
  SLE    20.377 (1)   .000 
  Gender*5-HTTLPR  0.008 (1)   .927 
  Gender*SLE              0.000 (1)   .988 
  5-HTTLPR*SLE  0.084 (1)   .772 
  5-HTTLPR*SLE*Gender 0.000 (1)   .995 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of  
gender, cohort, SLE (as measured by LEI reported between the ages of 17 and 25) and 5- 
HTTLPR (additive) on the presence of MDD between the ages of 17 and 25 years. 
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 SLE Group 
 
Figure 2.  Percentage of participants with Major Depressive Disorder (MDD) by 
genotype and SLE (LEI) group (comprised of quartiles). 
 
 
Dominance Analyses 
 The dominance analyses were much the same as the above-discussed additive 
analyses.  There was a significant main effect of SLE. No significant main effects for 
gender, cohort, or 5-HTTLPR were significant.  No interactions were significant.  For a 
summary of these results, please see Table 5. 
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Table 5 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, LEI, and 
5-HTTLPR on the presence of MDD at age 25 
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.001 (1)   .970 
  Cohort    3.572 (1)   .059 
  5-HTTLPR   0.704 (1)   .401 
  SLE    16.166 (1)   .000 
  Gender*5-HTTLPR  0.555 (1)   .456 
  Gender*SLE              0.144 (1)   .705 
  5-HTTLPR*SLE  0.478 (1)   .490 
  5-HTTLPR*SLE*Gender 0.250 (1)   .617 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of  
gender, cohort, SLE (as measured by LEI reported between the ages of 17 and 25) and 5- 
HTTLPR (dominance) on the presence of MDD between the ages of 17 and 25 years. 
 
 
Specific Aim 1b: Childhood Maltreatment 
 The next set of analyses focus on childhood maltreatment as a specific form of 
SLE.  In this case, instances of abuse and neglect were recorded by use of the Childhood 
Experience Questionnaire (CEQ).  The CEQ was administered to members of the 11-
year-old cohort at the age 25 assessment.  Using this retrospective questionnaire, the 
participants were asked to report on their experiences through the age of 18 years.  MDD 
was measured again as occurring between the ages of 17 and 25 years. 
Additive Analyses 
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 Results indicate no significant main effects of SLE, as measured by the CEQ, 
gender, cohort, or 5-HTTLPR on the presence of MDD at the age of 25 years.  No 
interactions were significant.  Please see Table 6 and Figure 3 for a summary of these 
results. 
 
Table 6   
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, CEQ, and 
5-HTTLPR on the presence of MDD at age 25 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.900 (1)   .343   
  5-HTTLPR   0.007 (1)   .932 
  SLE    3.124 (1)   .077 
  Gender*5-HTTLPR  0.011 (1)   .916 
  Gender*SLE              0.017 (1)   .895 
  5-HTTLPR*SLE  0.034 (1)   .854 
  5-HTTLPR*SLE*Gender 0.001 (1)   .978 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of  
gender, cohort, SLE (as measured by Childhood Experience Questionnaire – through age  
18 years) and 5-HTTLPR (additive) on the presence of MDD between the ages of 17 and  
25 years.  These analyses were completed only in the younger cohort because the CEQ  
was only administered to females in the older cohort. 
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 SLE Group 
 
Figure 3.  Percentage of participants with Major Depressive Disorder (MDD) by 
genotype and SLE (CEQ) group (comprised of quartiles). 
 
Dominance Analyses 
 When comparing S carriers to L homozygotes via dominance analyses, again no 
main effects were significant.  No interactions were significant, as was the case with the 
above discussed additive analyses.  Please see Table 7 for a summary of these results. 
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Table 7 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, CEQ, and 
5-HTTLPR on the presence of MDD at age 25  
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   1.545 (1)   .214  
  5-HTTLPR   0.150 (1)   .698 
  SLE    2.177 (1)   .140 
  Gender*5-HTTLPR  0.159 (1)   .690 
  Gender*SLE              0.166 (1)   .684 
  5-HTTLPR*SLE  0.150 (1)   .699 
  5-HTTLPR*SLE*Gender 0.128 (1)   .721 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, SLE (as measured by Childhood Experience Questionnaire – through age 
18 years) and 5-HTTLPR (dominance) on the presence of MDD between the ages of 17 
and 25 years.  These analyses were completed only in the younger cohort because the 
CEQ was only administered to females in the older cohort. 
 
 
Specific Aim 1c: Persistent MDD 
 Persistent MDD, for these analyses, was defined as the presence of MDD at two 
or more time points measured at the 17, 21, and 25 year assessments. 
Additive Analyses 
 The results indicate a significant main effect of SLE on the development of 
persistent MDD, where those exposed to higher numbers of SLE were more likely to 
experience persistent MDD.  No main effects of cohort, gender, or 5-HTTLPR were 
significant.  There was also a significant interaction between 5-HTTLPR and SLE on the 
presence of persistent MDD, where S/S individuals at higher rates of SLE actually 
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showed lower rates of MDD compared with S/L and L/L individuals, which is contrary to 
expectation.  Please see Table 8 and Figure 4 for a summary of these results. 
 
Table 8 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, LEI, and 
5-HTTLPR on persistent MDD by age 25 
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.049 (1)   .825 
  Cohort    1.369 (1)   .242 
  5-HTTLPR   2.652 (1)   .103 
  SLE    34.270 (1)   .000 
  Gender*5-HTTLPR  0.012 (1)   .914 
  Gender*SLE              2.170 (1)   .141 
  5-HTTLPR*SLE  4.117 (1)   .042 
  5-HTTLPR*SLE*Gender 0.522 (1)   .470 
 
 
Note.  Results of  Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, SLE (as measured by LEI reported between the ages of 17 and 25) and 5-
HTTLPR (additive) on the presence of persistent MDD between the ages of 17 and 25 
years. 
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        SLE Group 
 
Figure 4.  Percentage of participants with persistent Major Depressive Disorder (MDD) 
by genotype and SLE (LEI) group (comprised of quartiles). 
 
Dominance Analyses 
 When comparing S carriers to L homozygotes via dominance analyses, there was 
a significant main effect of SLE on the experience of MDD, where higher rates of SLE 
were related to higher rates of persistent MDD.  There was also a significant interaction 
of gender by SLE on the presence of MDD, where females exposed to higher rates of 
SLE were more likely to develop persistent MDD.  Again, there was also a significant 
interaction between 5-HTTLPR and SLE where S/S individuals showed lower rates of 
persistent MDD at higher rates of SLE compared with S/L and L/L individuals. All other 
main effects and interactions were non-significant.  Please see Table 9 for a summary of 
these results. 
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Table 9 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, LEI, and 
5-HTTLPR on persistent MDD by age 25 
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   1.649 (1)   .199 
  Cohort    1.200 (1)   .273 
  5-HTTLPR   3.912 (1)    .048 
  SLE    25.284 (1)   .000 
  Gender*5-HTTLPR  1.255 (1)   .263 
  Gender*SLE              2.595 (1)   .038 
  5-HTTLPR*SLE  4.365 (1)    .037 
  5-HTTLPR*SLE*Gender 2.377 (1)   .123 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, SLE (as measured by LEI reported between the ages of 17 and 25) and 5-
HTTLPR (dominance) on the presence of persistent MDD between the ages of 17 and 25 
years. 
 
Specific Aim 2: Independent versus Dependent SLE 
 The next set of analyses focused on potential differences in the gene by 
environment analyses when using independent versus dependent SLE.  First, independent 
SLE (those events unlikely to be influenced by the individual) were considered.  
Analyses focused on exposure to independent SLE between the 17 and 25 year 
assessments, as well as the presence of MDD during the same time frame. 
Additive Analyses on Independent SLE 
 Additive analyses indicated a significant main effect of independent SLE on the 
development of MDD, where those with higher rates of independent SLE were more 
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likely to experience MDD.  All other main effects and interactions were non-significant.  
Please see Table 10 and Figure 5 for summaries of these results. 
 
Table 10 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, 
independent LEI, and 5-HTTLPR on the presence of MDD at age 25 
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.320 (1)    .572 
  Cohort    1.567 (1)   .211 
  5-HTTLPR   0.024 (1)   .877 
  SLE    8.140 (1)   .004 
  Gender*5-HTTLPR  1.401 (1)   .236 
  Gender*SLE              0.258 (1)   .611 
  5-HTTLPR*SLE  0.234 (1)   .629 
  5-HTTLPR*SLE*Gender 1.512 (1)   .219 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, independent SLE (as measured by LEI reported between the ages of 17 
and 25) and 5-HTTLPR (additive) on the presence of MDD between the ages of 17 and 
25 years. 
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    SLE Group   
 
Figure 5.  Percentage of participants with Major Depressive Disorder (MDD) by 
genotype and independent SLE (LEI) group (comprised of quartiles). 
 
Dominance Analyses on Independent SLE 
 Next, L homozygotes were compared with S carriers.  As with the additive 
analyses, there was a significant main effect of independent SLE, where increases in 
independent SLE were related to higher rates of MDD.  No other main effects or 
interactions were significant.  For a summary of these results, see Table 11. 
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Table 11 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, 
independent LEI, and 5-HTTLPR on the presence of MDD at age 25 
 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.066 (1)   .797 
  Cohort    1.469 (1)   .266 
  5-HTTLPR   1.219 (1)   .270 
  SLE    7.552 (1)   .006 
  Gender*5-HTTLPR  3.506 (1)   .061 
  Gender*SLE              1.189 (1)   .276 
  5-HTTLPR*SLE  0.659 (1)   .417 
  5-HTTLPR*SLE*Gender 3.174 (1)   .075 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, independent SLE (as measured by LEI reported between the ages of 17 
and 25) and 5-HTTLPR (dominance) on the presence of MDD between the ages of 17 
and 25 years. 
 
Additive Analyses on Dependent SLE 
 Dependent SLE (those events that could be influenced or “selected” by 
individuals) were examined next.  Dependent SLE emerged as a significant predictor of 
MDD.  Those exposed to higher levels of dependent SLE were more likely to develop 
MDD.  There was no main effect of 5-HTTLPR and no significant interaction between 5-
HTTLPR and dependent SLE on the development of MDD.  For a summary of these 
results, please see Table 12 and Figure 6. 
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Table 12 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, dependent 
LEI, and 5-HTTLPR on the presence of MDD at age 25 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   1.995 (1)   .158 
  Cohort    4.694 (1)   .030 
  5-HTTLPR   0.091 (1)   .763 
  SLE    6.373 (1)   .012 
  Gender*5-HTTLPR  0.531 (1)    .466 
  Gender*SLE              0.665 (1)   .415 
  5-HTTLPR*SLE  0.217 (1)   .641 
  5-HTTLPR*SLE*Gender 1.358 (1)   .244 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, dependent SLE (as measured by LEI reported between the ages of 17 and 
25) and 5-HTTLPR (additive) on the presence of MDD between the ages of 17 and 25 
years. 
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    SLE Group 
 
Figure 6.  Percentage of participants with Major Depressive Disorder (MDD) by 
genotype and dependent SLE (LEI) group (comprised of quartiles). 
 
 
Dominance Analyses on Dependent SLE 
 Main effects of cohort and SLE on the development of MDD were seen.  Again, 
no main effect of genotype or an interaction between 5-HTTLPR and SLE were 
significant.  For a summary of these results, please see Table 13.   
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Table 13 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, dependent 
LEI, and 5-HTTLPR on the presence of MDD at age 25 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   0.452 (1)   .502 
  Cohort    4.592 (1)   .032 
  5-HTTLPR   0.780 (1)   .377 
  SLE    4.531 (1)   .033 
  Gender*5-HTTLPR  0.004 (1)   .951 
  Gender*SLE              0.090 (1)   .764 
  5-HTTLPR*SLE  0.205 (1)   .650 
  5-HTTLPR*SLE*Gender 0.198 (1)   .656 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, dependent SLE (as measured by LEI reported between the ages of 17 and 
25) and 5-HTTLPR (dominance) on the presence of MDD between the ages of 17 and 25 
years. 
 
Specific Aim 3: NEM, 5-HTTLPR, SLE, and MDD 
 The influence of 5-HTTLPR and Negative Emotionality (NEM) on the presence 
of MDD was investigated using the additive and dominance models.  For the means and 
standard deviations of NEM, and its facets (stress reactivity, alienation, and aggression) 
please see Table 14.  Levels of NEM did not vary across the three 5-HTTLPR variants, 
(F(2, 1381)=0.409, p=.664).  When males and females were examined separately, NEM 
still did not vary across the three 5-HTTLPR variants, (F(2, 640)=0.979, p=.376) for 
males and (F(2, 738)=2.580, p=.076) for females.  Similar results were found for the 
three facets of NEM, including stress reactivity (F(2, 1398)=1.251, p=.286), alienation 
(F(2, 1399)=1.999, p=.136) and aggression (F(2, 1398)=2.671, p=.070).     
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Table 14   
 
Mean (standard deviation) of Negative Emotionality (NEM), and its subscales Stress 
Reactivity, Alienation, and Aggression for each genotypic status. 
 
 
 N NEM   Stress Reactivity Alienation Aggression 
 
S/S 276 89.23 (14.56)  43.22 (9.56)  35.40 (9.03) 37.83 (10.11) 
 
S/L 657 89.43 (14.25)  43.63 (9.41)  35.35 (8.55) 37.27 (9.19) 
 
L/L 451 88.66 (13.42)  42.75 (8.64)  34.40 (7.89) 38.62 (9.85) 
 
 
Additive Analyses 
 It was further investigated whether NEM at age 17 was associated with MDD at 
age 25, and whether NEM interacted with SLE or 5-HTTLPR status on the presence of 
MDD at age 25, while continuing to investigate the potential effects of gender and cohort.  
Cohort and gender emerged as significant indicators of MDD.  NEM was not associated 
with the presence of MDD at age 25, nor were any interactions between NEM and SLE 
or 5-HTTLPR significant.  Please see Table 15 for these results.   
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Table 15 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, NEM, 
LEI, and 5-HTTLPR on the presence of MDD at age 25 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   11.439 (1)   .001 
  Cohort    7.526 (1)   .006 
  5-HTTLPR   0.869 (1)   .351 
  NEM    1.926 (1)   .165 
  SLE    0.513 (1)   .474 
  NEM*SLE   0.251 (1)   .616 
  NEM*5-HTTLPR  0.899 (1)   .343 
  NEM*5-HTTLPR*SLE 0.004 (1)   .952 
 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, NEM, SLE (as measured by LEI reported between the ages of 17 and 25) 
and 5-HTTLPR (additive) on the presence of MDD between the ages of 17 and 25 years 
in participants. 
 
Dominance Analyses 
 The dominance analyses were much the same as the additive analyses.  Again 
cohort was a significant predictor of the presence of MDD at age 25 years.  Gender also 
emerged as a significant predictor of MDD at age 25 years.  NEM was not significantly 
associated with the presence of MDD at age 25, nor were any interactions between NEM 
and either SLE or 5-HTTLPR significant.  Please see Table 16 for these results. 
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Table 16 
 
Results of Generalized Estimating Equations (GEE) examining gender, cohort, NEM, 
LEI, and 5-HTTLPR on the presence of MDD at age 25 
 
 
Phenotype Predictor   Wald Chi-Square (df)  p-value 
 
MDD  Gender   11.062 (1)   .001 
  Cohort    7.451 (1)   .006 
  5-HTTLPR   0.106 (1)   .745 
  NEM    1.089 (1)   .297 
  SLE    0.588 (1)   .443 
  NEM*SLE   0.224 (1)   .636 
  NEM*5-HTTLPR  0.060 (1)   .807   
  NEM*5-HTTLPR*SLE 0.005 (1)   .944 
 
Note.  Results of Generalized Estimating Equations (GEE) examining the effects of 
gender, cohort, NEM, SLE (as measured by LEI reported between the ages of 17 and 25) 
and 5-HTTLPR (dominance) on the development of presence of MDD between the ages 
of 17 and 25 years in participants. 
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Chapter 6: Discussion 
  
 The purpose of this project was to evaluate the interaction of 5-HTTLPR and 
stressful life events (SLE) on the presence of Major Depressive Disorder (MDD) in an 
epidemiological sample that as studied longitudinally.  First, an attempt at replicating 
Caspi et al. (2003) was made by investigating the potential interaction between 5-
HTTLPR variants and SLE on the presence of MDD at the age of 25.  While SLE showed 
a significant influence on the presence of MDD, the main effect of 5-HTTLPR and the 
interaction between SLE and 5-HTTLPR were non-significant.  Consequently, this 
current study was unable to replicate the original findings of Caspi et al. (2003). 
 In addition to the replication of Caspi, some potential arguments for the broad 
inconsistencies in the literature were examined.  First, childhood maltreatment was 
examined as a specific form of SLE that may interact with 5-HTTLPR variants (e.g., 
Karg et al., 2011) to produce MDD.  There were no significant main effects childhood 
maltreatment, 5-HTTLPR status, gender, or cohort on the presence of MDD at age 25.  
There were also no significant interactions between these variables on MDD, suggesting 
that childhood maltreatment is not a unique form of SLE more likely to elicit a gene by 
environment interaction. 
 Specific aim 1c focused on persistent MDD (e.g., two or more instances of MDD 
across three visits).  Again, there was a main effect for SLE influencing the presence of 
persistent MDD by the age of 25, and in the additive analysis, there was also an 
interaction between 5-HTTLPR and SLE on the presence of MDD.  However, this 
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interaction was found where S/S individuals were significantly less likely to exhibit 
MDD in response to high levels of stress compared with S/L and L/L individuals.  The 
dominance analysis also revealed a gender by SLE interaction where females exposed to 
higher rates of SLE were more likely to develop MDD. 
 In terms of whether findings might vary depending on the nature of life events 
experienced, both independent and dependent SLE appeared to have influenced the 
presence of MDD, with no difference between the two.  Facets of negative emotionality 
(NEM) were also examined.  Neither NEM nor interactions between NEM and SLE or 5-
HTTLPR significantly predicted the presence of MDD. 
 These findings would appear to contradict those presented and discussed in Caspi 
et al. (2003) and Caspi et al. (2010).  No significant interactions between 5-HTTLPR 
variants and SLE appeared to have influenced the presence of MDD in the predicted way 
where S carriers were more likely to exhibit MDD in response to higher levels of stress 
compared with L/L individuals.  As Caspi et al. (2010) suggested, one potential reason 
for lack of replication may be the use of paper/pencil questionnaires as opposed to in-
person interviews.  They argue that interviews are more appropriate because they allow 
for the interviewer to clarify the information collected, and they believe paper/pencil 
questionnaires offer inconsistent and “idiosyncratic” results (Monroe 2008; Dohrenwend 
2006).  The SLE data used in these analyses from the LEI were part of in-depth in-person 
interviews and still no relationship between 5-HTTLPR and SLE was found for MDD.  
Despite Karg et al.’s (2011) suggestion that childhood maltreatment may be an especially 
important form of SLE in this gene by environment interaction research, childhood 
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maltreatment did not emerge as a form of SLE that interacted with 5-HTTLPR to 
contribute to the presence of MDD.   
 Although these results do not support the findings of Caspi et al. (2003), findings 
from this current project are consistent with several publications.  In a meta-analysis, 
Risch et al. (2009), found SLE to be a significant predictor of MDD, but also did not find 
an interaction between 5-HTTLPR and SLE on MDD.  Furthermore, these current 
findings support the many articles that have criticized the 5-HTTLPR and SLE 
interaction literature.  For instance, Duncan and Keller (2011) have suggested this area of 
research is heavily influenced by publication bias, which is supported by numerous 
attempts at replication, which have not been successful.   
 In addition to the potential influences of publication bias, other differences 
between the current project and the original Caspi et al. (2003) may have influenced 
differential findings.  The original Caspi paper was not based on twins, whereas the 
analyses in this current project involve a sample of twins.  Additionally, Caspi et al. 
(2003) focused on stress between the ages of 21 and 26 years, and included MDD that 
developed between ages 25 and 26.  The current study used stress and MDD occurring 
concurrently between the ages of 17 and 25 years.  With stress and MDD occurring 
concurrently, it is possible people with MDD reported more stress during this period.     
 While no evidence for gene by environment interactions were found in this 
current project, the findings do support the well-established relationship between life 
stress and depression that has been reported for decades (e.g., Hammen 2005).  The main 
effect of SLE on the presence of MDD was clearly significant, supporting the idea that 
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greater exposure to stressors increases an individual’s risk of experiencing MDD.  Even 
when separating out dependent and independent SLE, both remained significant 
predictors of MDD, suggesting that regardless of the kind of SLE present, there is still a 
significant relationship between SLE and MDD.  From a clinical standpoint, it suggests 
that psychotherapeutic interventions for those experiencing stress may decrease future 
instances of MDD.  Improving social support for those experiencing stress may also 
decrease subsequent psychopathology.  For instance, some work has suggested that 
improving living conditions and support for children exposed to stress may decrease 
problematic emotional responses later in development (e.g., Gunnar & Quevedo, 2007).   
 
Potential Reasons for Non-Replication 
 Although the findings of this current study do not support the gene by 
environment interaction elucidated by Caspi et al. (2003), there are several reasons why 
such inconsistencies in data analyses may be seen.  Some of these further reasons for 
discrepancies within the literature are examined in this section.   
 
Methodological Differences between the Current Study and Caspi et al. (2003) 
 As mentioned briefly above, the timing of the stress and MDD reports differ 
between the current study and the original Caspi publication.  The original Caspi et al., 
(2003) had individuals report their stress between the ages of 21 and 26 years of age.  
Then, they examined MDD occurring between the ages of 25 and 26 years.  The current 
study examines SLE and MDD between the ages of 17 and 25 years.  The differences in 
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timing could account for differences in findings.  Additionally, the original Caspi et al. 
(2003) sample did not include twins, and the current study’s sample did. 
 
Development 
 The timing of early life stress can play an important role in the development of 
pathology.  Young children, during certain periods, when exposed to childhood 
maltreatment or parental deprivation appear to experience differential levels of risk for 
developing behavioral problems.  For instance, Gunnar et al. (2007) found that children 
adopted after the age of 24 months were more likely to exhibit behavioral difficulties 
compared with children adopted into families prior to this specific age.  Additionally, in a 
retrospective study, Andersen et al. (2008) found that young adult women who had a 
history of sexual abuse between the ages of 3 and 5 years and again between 11 and 13 
years had smaller hippocampal volumes, while those who experienced sexual abuse 
between the ages of 14 and 16 years had smaller frontal cortical volume.   
In terms of MDD, one study suggests children losing a parent prior to the age of 9 
years are more likely to develop MDD than children losing a parent after the age of 9 
(Agid et al., 1999).  Another study suggests political traumatization occurring prior to the 
age of 12 years is more likely to result in MDD compared with similar trauma after the 
age of 12, which is more likely to result in Post-Traumatic Stress Disorder (Maercker et 
al., 2004).  As suggested by the ages of the participants in Agid et al. (1999) and 
Maercker et al. (2004), pubertal maturation may mark a particularly vulnerable time 
period for environmental stressors and the impact of such stressors on later development.  
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During puberty, the hypothalamic pituitary adrenal (HPA) axis, which is involved in 
stress reactivity, is undergoing maturational changes and this time period may see 
additional vulnerabilities to stress, compared with other developmental stages (Heim & 
Binder, 2012). 
Taken together, these studies suggest stress during certain early time frames may 
have greater or lesser impacts on pathological psychological or biological development.  
Consequently, it is fathomable that the timing of certain stressors may also influence the 
main effects of 5-HTTLPR on MDD, and thus also the interactions that were examined 
(Heim & Binder, 2012).  The current study involves participants at the ages of 11 and 17 
years at intake, and examines the influences of stress at the later ages between 20 and 25, 
which is similar to the age ranges studied by Caspi et al. (2003).  The current study, as 
well as Caspi et al. (2003), does not take into account previous SLE that may have 
happened during developmentally sensitive periods, such as during pubertal maturation.  
While the current study overlaps with the time frame studied by Caspi et al. (2003), 
developmental differences could contribute to the discrepancies seen in the literature on 
the whole.  Therefore, work could be done examining genetics and stress during different 
developmentally sensitive periods.   
  
5-HTTLPR and rs25531 
Another potential complication in 5-HTT research involves the SNP, rs25531.  
Numerous recent studies have included the SNP, rs25531, in 5-HTTLPR analyses.  With 
rs25531, individuals can either have A and/or G alleles.  The A allele, is far more 
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frequent and is associated with higher serotonergic expression.  On the other hand, the 
relatively rare G allele is associated with lower serotonergic expression.  When 
considering the 5-HTTLPR in conjunction with rs25531, the G allele renders the L allele 
functionally equivalent to the S allele.  Therefore, in studies where rs25531 genotypes are 
acquired, individuals with the G allele are typically grouped with the S carriers (Hu, et 
al., 2005).  Wendland, and colleagues (2006) reported the following allelic frequencies: 
SA (43.5%), SG (0.25%), LA (50.5%), and LG (6.5%).  These reported rates appear similar 
to several other studies reporting these frequencies in Caucasians (e.g., Beevers et al., 
2011; Quaak, van Schzyck, Postma, Wagena, & van Schooten, 2011). 
Some articles have reported that allelic differences in rs25531 lead to certain 
functional differences.  For instance, G carriers, when compared with A carriers, exhibit 
differential attentional biases (Fox, Ridgewell, & Ashwin, 2009; Kwang, Wells, 
McGeary, Swann, & Beevers, 2010), have greater amygdala response to emotional 
stimuli (Dannlowski et al., 2007), show greater error related activation in the nucleus 
accumbens (Holmes, Bogdan, & Pizzagalli, 2010), and experience irritable bowel 
syndrome more frequently (Kohen, et al., 2009).  Also G carriers may experience 
treatment resistant depression at higher rates than A carriers (Bonvicini et al., 2010).     
While some studies suggest rs25531 is an important SNP to consider when 
investigating 5-HTTLPR, several other studies fail to find differences between G and A 
carriers in relation to several phenotypes, including Alzheimer’s Disease (Polito et al., 
2011), depression (Antypa & van der Does, 2010; Coventry et al., 2010; Wray et al., 
2009), depression in survivors of traumatic brain injury (Chan et al., 2008), suicide 
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(Coventry et al., 2010; Segal et al., 2009), depression in survivors of stroke (Kohen et al., 
2008; Mak, Kong, Mak, Sharma, & Ho 2013), depression in individuals with Parkinson’s 
disease (Zhang et al., 2009), cognitive deficiencies in schizophrenics (Konneker et al., 
2010), premenstrual dysphoric disorder (Magnay et al., 2010), bipolar disorder (Pinto et 
al., 2011), alcohol and nicotine consumption (Rasmussen et al., 2009), borderline 
personality disorder (Tadic et al., 2010), and obsessive-compulsive disorder  (Wendland  
et al., 2007).  Furthermore, since G carriers are relatively rare, some researchers have 
explicitly said that including the rs25531 in their 5-HTTLPR data analyses failed to 
change their results (e.g., Beitchman et al., 2006; Sonuga-Barke et al., 2011; Antypa & 
van der Does, 2010).  Due to the relatively low rates of G carriers, and the inconsistency 
of these findings, LG / LA status was not considered for this current project, although it is 
conceivable that individual variation in the rs25531 may play a part in the inconsistencies 
with 5-HTTLPR by SLE interaction literature.  However, given the relatively small 
number of LG individuals, its influence would likely be minimal. 
 
Presence of SSRI Medication 
 Another factor that may contribute to discrepancies in findings involves the use of 
selective serotonin reuptake inhibitors (SSRIs).  According to the Centers for Disease 
Control (CDC) 11% of Americans took SSRI medication in 2011 and between 1988 and 
2008, there was a 400% increase in the use of SSRI medications amongst Americans.  
Since this medication targets the 5-HTT system, it is plausible that the presence of SSRI 
medication may make the influence of 5-HTTLPR on the presence of MDD harder to 
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detect.  Consequently, it may also make gene by environment interactions more difficult 
to find.  For instance, Scheid and colleagues (2007) initially did not find an interaction 
between 5-HTTLPR and SLE on the presence of MDD.  However, when they eliminated 
the 13% of their sample that was taking psychotropic medication, they were able to find 
this gene by environment effect.  Since the popularity of SSRI medication has grown 
exponentially since 1988, many more individuals are on this medication, which could 
complicate the results of more recent gene by environment studies. 
 
Nature of SLE 
 Although this current project looked at different sorts of SLE (e.g., dependent 
versus independent SLE), still others may be responsible for the gene by environment 
interaction.  Vrshek-Schallhorn and colleagues (2014) have suggested that interpersonal 
SLE and family stress are specific forms of SLE that may interact with 5-HTTLPR and 
lead to MDD.  These authors argue that interpersonal SLE represent social loss and might 
be more likely to evoke a depressive response.  Their findings suggest S carriers, when 
compared with L/L homozygotes were more likely to experience MDD in the presence of 
interpersonal SLE.    
 Therefore, while the current study fails to demonstrate a gene by environment 
interaction on the presence of MDD, it does not rule out the importance of serotonin in 
pathogenesis of MDD.  Moreover, these results do not indicate the gene by environment 
findings are false.  This study, instead, illustrates the difficulties in finding significant 
gene by environment interactions due to several inconsistent and heterogenous factors in 
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data.  For instance, several factors including the timing of SLE, rs25531 status, and the 
ever increasing use of SSRI medications may all influence data analyses used to examine, 
replicate, and expand upon the original findings in Caspi et al. (2003).  
  
Limitations 
Future research in the area of 5-HTTLPR by SLE interaction research would 
benefit from taking into account potential differences in developmental time periods.  As 
discussed above, different developmental periods may confer differing levels of risk to 
environmental stressors (Heim & Binder, 2012).  Additionally, future studies can 
continue to examine the type of stressor.  In the current project, the childhood 
maltreatment information came from a retrospective questionnaire, which can be plagued 
by problems associated with memory.  Concurrent measures of childhood maltreatment 
may be more likely to elicit gene by environmental findings.   
 Statistical power, on the whole, is another issue plaguing much of the gene by 
environment interaction research.  While the sample in this current study was relatively 
large, several other publications have relied on samples in the low hundreds.  Considering 
Murphy and colleagues indicate only about 1% of the variance in amygdala reactivity is 
related to 5-HTTLPR status, any interaction 5-HTTLPR may have with SLE on 
behavioral phenotypes is potentially smaller.   
 While the longitudinal data collected and maintained by the MCTFR allow for 
several complex analyses, there are limitations within this design.  For instance, there are 
two different cohorts that are combined for analyses.  The CEQ was only used in analyses 
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including the younger cohort, as the older cohort males did not complete this 
questionnaire.   
 Despite the limitations of the current study, it provides support for the role of SLE  
in the presence of MDD.  Like many other publications, the results suggest some 
skepticism regarding any potential 5-HTTLPR by SLE interaction on MDD, although 
several potential reasons for these inconsistencies in this literature have been proposed 
and discussed.      
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Appendix A. 
Stressful Life Events from the Life Events Interview (LEI).   
1. Have you moved? 
2. Have you moved more than 50 miles? 
3. Have you had a serious problem with a friend? 
4. Were you unable to see, or lost, your friend? 
5. Have you had a close friend seriously ill or injured? 
6. Have you had a friend die? 
7. Have you had a pet die? 
8. Have you had a relative die? 
9. Have you had a widowed parent remarry? 
10. Has your family experienced money problems? 
11. Have your parents divorced? 
12. Have you had a divorced parent remarry? 
13. Have you (or a partner) worried about being pregnant? 
14. Have you (or a partner) been pregnant? 
15. Have you (or a partner) given birth? 
16. Have you (or a partner) has a miscarriage or abortion? 
17. Have you (or a partner) given a child up for adoption? 
18. Have you been separated from your spouse? 
19. Has your spouse been unfaithful to you? 
20. Have you been unfaithful to your spouse? 
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21. Have you gotten divorced? 
22. Has your former spouse remarried? 
23. Have you been widowed? 
24. As an adult, have you received welfare or aid? 
25. As an adult, have you had welfare or aid cut off? 
26. Have you lost a job? 
27. Have you been unemployed for a period of 6 months or more? 
28. Have you had trouble with alcohol or drugs? 
29. Have any members of your family had trouble with alcohol or drugs? 
30. Have you had traffic citations? 
31. Have you had trouble with the police? 
32. Have you gone to court? 
33. Have you been adjudicated as a juvenile? 
34. Have you had a family member arrested? 
35. Have you had a family member sent to jail? 
36. Has any family member had a serious illness? 
37. Has any family member had a serious injury? 
38. Have you seen a serious accident? 
39. Have you been a driver in a serious accident? 
40. Has a family member attempted suicide? 
41. Has a family member completed suicide? 
42. Have you received any psychiatric hospitalizations? 
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43. Have you been robbed or mugged? 
44. Has a member of your family been a victim of violence? 
45. Have you experienced sexual harassment? 
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Appendix B. 
Stressful Life Events from the Childhood Events Questionnaire (CEQ).  Please note, not 
all of these questions were asked at each time point. 
1. Before the age of 9 years, did your parents ever leave you alone? 
2. Did your parents ever forget to do important things for you? 
3. Did your parents ever act so badly you were embarrassed? 
4. Did your parents call you inappropriate names? 
5. Did your parents torment you with scary things (like snakes or ghosts)? 
6. Did your parents threaten to leave you? 
7. Did your parents ever confine you to a dark, small place? 
8. Did your parents ever threaten to hurt you or something you cared about? 
9. Did your parents ever destroy anything of yours, including a pet? 
10. Were you spanked? 
11. Were you spanked so hard it left marks? 
12. Were you hit with objects? 
13. Were you hurt with a weapon? 
14. Were you hurt in other ways? 
15. Did anyone ask you to do something sexual? 
16. Did someone expose his/herself to you? 
17. Did anyone have you expose yourself? 
18. Were you ever forced to engage in sexual acts? 
19. Were your sexual parts ever fondled? 
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20. Did anyone ask you to fondle his/her sexual parts? 
21. Did anyone put his/her hands inside of you or perform sexual acts with his/her 
mouth? 
22. Did anyone force you to put your hands inside of them or do sexual things to 
him/her with your mouth? 
23. Did anyone attempt to force you into intercourse? 
24. Did you ever experience sexual assault involving force, physical restraint, or 
threats of physical violence? 
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Appendix C. 
Independent and dependent adverse life events from Bemmel, Burt, Legrand, Iacono, and 
McGue (2008).   
 
Event Class: Independent 
 4 items 
1. Have you had a close friend move away so you couldn’t see them any 
more?   
2. Was a close friend of yours ever seriously ill or hurt?   
3. Has a close friend of yours died?   
4. Were you ever mugged or robbed?   
 
Event Class: Dependent 
 9 items 
1. Have you ever had a serious problem with a close friend?   
2. Have you and a romantic partner ever broken up?   
3. Have you or your romantic partner become pregnant?   
4. Have you or your romantic partner given birth to a child?   
5. Did you or your romantic partner ever have an abortion?   
6. Have you ever gotten into trouble because of your use of drugs or 
alcohol?   
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7. Have you ever been in trouble with the police (for traffic violations or 
any other reason)?       
8. Have you ever had to go to court?   
9. Were you ever sent to a juvenile detention center (jail)?  
 
 
 
 
 
 
